Perfil
Andreas Maetzel served as Vice President-Global Medical Affairs at BioCryst Pharmaceuticals, Inc. from 2014 to 2017.
Prior to that, he was VP-Clinical Development & Regulatory Affairs at Cornerstone Therapeutics, Inc. from 2013 to 2014.
He also worked as Senior Vice President-Medical at KalVista Pharmaceuticals, Inc. Dr. Maetzel holds a graduate and doctorate degree from the University of Toronto and a doctorate degree from the University of Hannover.
Antiguos cargos conocidos de Andreas Maetzel.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2017 |
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2014 |
| KALVISTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Andreas Maetzel.
| University of Toronto | Doctorate Degree |
| University of Hannover | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Andreas Maetzel
